|
시장보고서
상품코드
2054972
아세트아미노펜 시장 : 제품 형태별, 투여 경로별, 용도별, 제품 유형별, 판매 형태별, 연령층별, 성별, 함유량별, 유통 채널별, 최종사용자별, 지역별Acetaminophen Market, By Product Form, By Route of Administration, By Application, By Product Type, By Sales Type, By Age Group, By Gender, By Strength, By Distribution Channel, By End User, By Geography |
||||||
아세트아미노펜 시장은 2026년에 109억 7,000만 달러로 추계되고 있으며, 2033년까지 153억 4,000만 달러에 달할 것으로 전망되고 있습니다. 2026-2033년에는 CAGR 4.9%로 성장할 것으로 예측됩니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 109억 7,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 4.90% | 2033년 시장 규모 예측 : | 153억 4,000만 달러 |
전 세계 아세트아미노펜 시장은 제약 업계에서 매우 중요한 부문을 차지하고 있으며, 전 세계에서 가장 널리 사용되는 일반의약품 진통·해열제 중 하나를 포함하고 있습니다. 많은 지역에서 파라세타몰로도 알려진 아세트아미노펜은 다양한 인구 집단에서 통증 관리 및 해열을 위한 기본적인 치료제로 사용되고 있습니다. 이 필수 의약품 성분은 수십년에 걸친 임상 검증을 통해 시장에서 우위를 유지해 왔으며, 적절하게 사용될 경우 경증에서 중등도의 통증 치료에 있으며, 일관된 효능을 발휘함과 동시에 우수한 안전성 프로파일을 보여주고 있습니다.
이 시장에는 정제, 캡슐, 액상 현탁액, 복합제제 등 다양한 제형이 포함되어 있으며, 전 세계의 소아, 성인, 노인 환자층을 대상으로 하고 있습니다. 제조 거점은 확립된 제약 허브부터 신흥 시장까지 폭넓게 구축되어 있으며, 다국적 기업과 지역 기업 모두에 걸쳐 상당한 생산 능력이 분산되어 있습니다. 시장의 견고한 성장세는 아세트아미노펜이 전 세계 필수 의약품 리스트에 포함되어 있다는 점, 대체 진통제에 비해 비용 대비 효과가 높다는 점, 그리고 다수의 관할 구역에서 광범위하게 규제 승인을 받았다는 점에 기인합니다. 약국 소매 채널, 슈퍼마켓, 그리고 점점 더 확대되고 있는 E-Commerce 플랫폼을 통한 소비자의 접근성은 아세트아미노펜의 시장 입지를 더욱 공고히 하고 있습니다. 한편, 새로운 투여 기전 및 병용 요법에 대한 연구가 지속적으로 진행되고 있으며, 이는 이 확립된 의약품 분야에서 혁신을 주도하고 있습니다.
시장 역학
전 세계 아세트아미노펜 시장은 다양한 치료 용도와 지역에 걸친 수요를 종합적으로 촉진하는 상호 연관된 여러 요인의 견인 아래 견고한 성장세를 보이고 있습니다. 주요 시장 성장 요인으로는 전 세계 만성 통증 질환 유병률의 증가, 정기적인 통증 관리 솔루션이 필요한 고령 인구 증가, 그리고 비스테로이드성 항염증약(NSAIDs)에 비해 아세트아미노펜이 뛰어난 안전성 프로파일을 갖추고 있다는 인식이 높아지고 있는 점을 들 수 있습니다. 일반의약품의 접근성 확대와 자가치료에 대한 소비자의 선호도 증가는 시장 진입을 크게 촉진하고 있는 반면, 신흥 국가에서의 의료비 지출 증가는 시장 침투를 위한 큰 기회를 창출하고 있습니다.
또한 아세트아미노펜은 다른 유효 성분과 복합 제제로 제조할 때 활용도가 높아, 치료적 유용성과 시장에서의 매력을 높이고 있습니다. 그러나 시장에는 간독성 우려로 인한 투여량 제한을 규정하는 엄격한 규제 체계, 대체 통증 관리 요법과의 경쟁 심화, 과다 복용에 따른 잠재적 부작용에 대한 소비자의 인식 제고 등 상당한 제약 요인이 존재합니다. 원자재 가격 변동 및 공급망 혼란과 관련된 제조상의 문제 역시 시장의 성장 잠재력을 더욱 제한하고 있습니다. 한편, 약물전달 시스템의 기술적 진보, 서방형 제제의 개발, 그리고 의료 인프라가 제한적이고 의료 서비스가 충분히 제공되지 않는 지역 시장으로의 진출을 통해 큰 기회가 창출되고 있습니다.
본 조사의 주요 특징.
- 본 조사에서는 각 부문의 잠재적 매출 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 항목(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략)을 바탕으로 전 세계 아세트아미노펜 시장의 주요 기업 개요을 작성했습니다.
- 이 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 아세트아미노펜 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 아세트아미노펜 시장을 분석하는 데 활용되는 다양한 전략 매트릭스를 통해 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 아세트아미노펜 시장 : 제품 형태별, 2021-2033년
제5장 세계의 아세트아미노펜 시장 : 투여 경로별, 2021-2033년
제6장 세계의 아세트아미노펜 시장 : 용도별, 2021-2033년
제7장 세계의 아세트아미노펜 시장 : 제품 유형별, 2021-2033년
제8장 세계의 아세트아미노펜 시장 : 판매 유형별, 2021-2033년
제9장 세계의 아세트아미노펜 시장 : 연령층별, 2021-2033년
제10장 세계의 아세트아미노펜 시장 : 성별, 2021-2033년
제11장 세계의 아세트아미노펜 시장 : 강도별, 2021-2033년
제12장 세계의 아세트아미노펜 시장 : 유통 채널별, 2021-2033년
제13장 세계의 아세트아미노펜 시장 : 최종사용자별, 2021-2033년
제14장 세계의 아세트아미노펜 시장 : 지역별, 2021-2033년
제15장 경쟁 구도
제16장 애널리스트의 제안
제17장 참고 문헌 및 조사 방법
KSA 26.06.18Acetaminophen Market is estimated to be valued at USD 10.97 Bn in 2026 and is expected to reach USD 15.34 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 10.97 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.90% | 2033 Value Projection: | USD 15.34 Bn |
The global acetaminophen market represents a critical segment within the pharmaceutical industry, encompassing one of the world's most widely used over-the-counter analgesic and antipyretic medications. Acetaminophen, also known as paracetamol in many regions, serves as a cornerstone therapeutic agent for pain management and fever reduction across diverse demographic populations. This essential pharmaceutical compound has maintained its market prominence through decades of clinical validation, demonstrating consistent efficacy in treating mild to moderate pain conditions while exhibiting a favorable safety profile when used appropriately.
The market encompasses various formulations including tablets, capsules, liquid suspensions, and combination products, catering to pediatric, adult, and geriatric patient populations globally. Manufacturing operations span across established pharmaceutical hubs and emerging markets, with significant production capacities distributed among both multinational corporations and regional players. The market's resilience stems from acetaminophen's inclusion in essential medicine lists worldwide, its cost-effectiveness compared to alternative analgesics, and its widespread regulatory approval across numerous jurisdictions. Consumer accessibility through pharmacy retail channels, supermarkets, and increasingly through e-commerce platforms has further solidified acetaminophen's market position, while ongoing research into novel delivery mechanisms and combination therapies continues to drive innovation within this established pharmaceutical segment.
Market Dynamics
The global acetaminophen market experiences robust growth driven by several interconnected factors that collectively enhance demand across multiple therapeutic applications and geographic regions. Primary market drivers include the escalating global prevalence of chronic pain conditions, increasing geriatric populations requiring regular pain management solutions, and rising awareness of acetaminophen's favorable safety profile compared to non-steroidal anti-inflammatory drugs (NSAIDs). The expanding over-the-counter availability and consumer preference for self-medication practices significantly boost market accessibility, while growing healthcare expenditure in emerging economies creates substantial opportunities for market penetration.
Additionally, the versatility of acetaminophen in combination formulations with other active pharmaceutical ingredients enhances its therapeutic utility and market appeal. However, the market faces considerable restraints including stringent regulatory frameworks governing dosage limitations due to hepatotoxicity concerns, increasing competition from alternative pain management therapies, and growing consumer awareness of potential adverse effects associated with overdose scenarios. Manufacturing challenges related to raw material price volatility and supply chain disruptions further constrain market growth potential. Conversely, significant opportunities emerge through technological advancements in drug delivery systems, development of sustained-release formulations, and expansion into underserved geographic markets with limited healthcare infrastructure.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global acetaminophen market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include GlaxoSmithKline (GSK), Kenvue, Haleon, Sanofi, Abbott, Reckitt, MICRO LABS LTD., Taisho Pharmaceutical, Teva Pharmaceutical Industries, Dr. Reddy's Laboratories, Aurobindo Pharma, Sun Pharmaceutical Industries, Granules India, and Perrigo Company
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global acetaminophen market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global acetaminophen market
Market Segmentation
- Product Form Insights (Revenue, USD Bn, 2021 - 2033)
- Tablets
- Liquid Suspensions
- Capsules
- Suppositories
- Others (Powder/Granules, etc.)
- Route Of Administration Insights (Revenue, USD Bn, 2021 - 2033)
- Oral
- Parenteral
- Others (Rectal, etc.)
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Pain Management (Mild, Moderate, Severe Pain)
- Fever Reduction
- Others (Cold and Flu Treatment, etc.)
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Single Formulation (Acetaminophen-only)
- Combination Formulations (Acetaminophen with opioids, NSAIDs, antihistamines, or decongestants)
- Sales Type Insights (Revenue, USD Bn, 2021 - 2033)
- OTC (Over-the-Counter)
- Prescription
- Age Group Insights (Revenue, USD Bn, 2021 - 2033)
- Adult
- Pediatric
- Geriatric
- Gender Insights (Revenue, USD Bn, 2021 - 2033)
- Male
- Female
- Strength Insights (Revenue, USD Bn, 2021 - 2033)
- Low (up to 325 mg)
- Standard (500 mg)
- High (above 500 mg)
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Clinics
- Homecare Settings
- Others (Nursing Homes, Emergency Care Units)
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- GlaxoSmithKline (GSK)
- Kenvue
- Haleon
- Sanofi
- Abbott
- Reckitt
- MICRO LABS LTD.
- Taisho Pharmaceutical
- Teva Pharmaceutical Industries
- Reddy's Laboratories
- Aurobindo Pharma
- Sun Pharmaceutical Industries
- Granules India
- Perrigo Company
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Acetaminophen Market, By Product Form
- Global Acetaminophen Market, By Route of Administration
- Global Acetaminophen Market, By Application
- Global Acetaminophen Market, By Product Type
- Global Acetaminophen Market, By Sales Type
- Global Acetaminophen Market, By Age Group
- Global Acetaminophen Market, By Gender
- Global Acetaminophen Market, By Strength
- Global Acetaminophen Market, By Distribution Channel
- Global Acetaminophen Market, By End User
- Global Acetaminophen Market, By Country
3. Market Dynamics, Regulations, And Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Acetaminophen Market, By Product Form, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Liquid Suspensions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Suppositories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Powder/Granules, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Acetaminophen Market, By Route of Administration, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Rectal, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Acetaminophen Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pain Management (Mild, Moderate, Severe Pain)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Fever Reduction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Cold and Flu Treatment, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Acetaminophen Market, By Product Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Single Formulation (Acetaminophen-only)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Combination Formulations (Acetaminophen with opioids, NSAIDs, antihistamines, or decongestants)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Acetaminophen Market, By Sales Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- OTC (Over-the-Counter)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Prescription
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Acetaminophen Market, By Age Group, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Acetaminophen Market, By Gender, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
11. Global Acetaminophen Market, By Strength, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Low (up to 325 mg)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Standard (500 mg)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- High (above 500 mg)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
12. Global Acetaminophen Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
13. Global Acetaminophen Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Nursing Homes, Emergency Care Units)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
14. Global Acetaminophen Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sales Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sales Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sales Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sales Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sales Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sales Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
15. Competitive Landscape
- GlaxoSmithKline (GSK)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Kenvue
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Haleon
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Reckitt
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- MICRO LABS LTD.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Taisho Pharmaceutical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Reddy's Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aurobindo Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Granules India
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Perrigo Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
16. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
17. References and Research Methodology
- References
- Research Methodology
- About us
